Stefan K.F. Schwabe
2019
In 2019, Stefan K.F. Schwabe earned a total compensation of $1.5M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,900 |
|---|---|
| Option Awards | $885,020 |
| Salary | $401,175 |
| Other | $31,961 |
| Total | $1,469,056 |
Schwabe received $885K in option awards, accounting for 60% of the total pay in 2019.
Schwabe also received $150.9K in non-equity incentive plan, $401.2K in salary and $32K in other compensation.
Rankings
In 2019, Stefan K.F. Schwabe's compensation ranked 7,408th out of 13,971 executives tracked by ExecPay. In other words, Schwabe earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,408 out of 13,971 | 47th |
Division Manufacturing | 2,866 out of 5,701 | 50th |
Major group Chemicals And Allied Products | 1,073 out of 2,200 | 51st |
Industry group Drugs | 914 out of 1,886 | 52nd |
Industry Pharmaceutical Preparations | 676 out of 1,398 | 52nd |
Pay ratio
| Stefan K.F. Schwabe's Pay | $1,469,056 |
|---|---|
| Median Employee's Pay | $135,666 |
| Pay Ratio | 11to 1 |
In 2019, the annual total compensation of Stefan K.F. Schwabe was $1,469,056.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $135,666.
The ratio of Stefan K.F. Schwabe's pay to the pay of median employee was therefore 11 to one.
Source: SEC filing on April 24, 2020.
Schwabe's colleagues
We found four more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2019.